Long-term swallow function after chemoradiotherapy for oropharyngeal cancer: The influence of a prophylactic gastrostomy or reactive nasogastric tube

Clinical Oncology

Volumn 26, Issue 2, 2014, Pages 103-109

  Prestwich, R J D ^a   Teo, M T W ^a   Gilbert, A ^b   Williams, G ^a   Dyker, K E ^a   Sen, M ^a  

^a St James's Institute of Oncology   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Chemoradiotherapy; Gastrostomy; Nasogastric tube; Oropharynx cancer; Swallow; Toxicity

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CHEMORADIOTHERAPY; COMPARATIVE STUDY; ENTERIC FEEDING; FEMALE; FOLLOW UP; GASTROSTOMY; HIGH RISK PATIENT; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NASOGASTRIC TUBE; OROPHARYNX CANCER; OROPHARYNX SQUAMOUS CELL CARCINOMA; PATIENT PREFERENCE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; SWALLOWING;

CHEMORADIOTHERAPY; GASTROSTOMY; NASOGASTRIC TUBE; OROPHARYNX CANCER; SWALLOW; TOXICITY;

ADULT; AGED; CHEMORADIOTHERAPY; COHORT STUDIES; DEGLUTITION; ENTERAL NUTRITION; FEMALE; GASTROSTOMY; HUMANS; INTUBATION, GASTROINTESTINAL; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; TREATMENT OUTCOME;

EID: 84892478364     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2013.10.005     Document Type: Article

References (25)

1. Forastiere A.A., Goepfert H., Maor M., et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. NEngl J Med 2003, 349(22):2091-2098.
2. Adelstein D.J., Li Y., Adams G.L., et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. JClin Oncol 2003, 21(1):92-98.
3. Clavel S., Fortin B., Despres P., et al. Enteral feeding during chemoradiotherapy for advanced head-and-neck cancer: a single-institution experience using a reactive approach. Int J Radiat Oncol Biol Phys 2011, 79(3):763-769.
4. Nguyen N.P., North D., Smith H.J., et al. Safety and effectiveness of prophylactic gastrostomy tubes for head and neck cancer patients undergoing chemoradiation. Surg Oncol 2006, 15(4):199-203.
5. Ho Joon Wee, Donaldson M., Christian J. Outcomes of gastrostomy feeding tubes in patients undergoing primary chemoradiation for oral cavity, oropharynx, hypopharynx and larynx squamous cell carcinoma (SCC) at Nottingham University NHS Trust: a retrospective analysis 2004-2008. Clin Oncol 2011, 23(3):S39.
6. Koyfman S.A., Adelstein D.J. Enteral feeding tubes in patients undergoing definitive chemoradiation therapy for head-and-neck cancer: a critical review. Int J Radiat Oncol Biol Phys 2012, 84(3):581-589.
7. Eisbruch A., Kim H.M., Feng F.Y., et al. Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates. Int J Radiat Oncol Biol Phys 2011, 81(3):e93-e99.
8. Moor J.W., Patterson J., Kelly C., Paleri V. Prophylactic gastrostomy before chemoradiation in advanced head and neck cancer: a multiprofessional web-based survey to identify current practice and to analyse decision making. Clin Oncol (R Coll Radiol) 2010, 22(3):192-198.
9. Corry J., Poon W., McPhee N., et al. Prospective study of percutaneous endoscopic gastrostomy tubes versus nasogastric tubes for enteral feeding in patients with head and neck cancer undergoing (chemo)radiation. Head Neck 2009, 31(7):867-876.
10. Williams G.F., Teo M.T., Sen M., et al. Enteral feeding outcomes after chemoradiotherapy for oropharynx cancer: a role for a prophylactic gastrostomy?. Oral Oncol 2012, 48(5):434-440.
11. Paleri V., Patterson J. Use of gastrostomy in head and neck cancer: a systematic review to identify areas for future research. Clin Otolaryngol 2010, 35(3):177-189.
12. Salas S., Baumstarck-Barrau K., Alfonsi M., et al. Impact of the prophylactic gastrostomy for unresectable squamous cell head and neck carcinomas treated with radio-chemotherapy on quality of life: prospective randomized trial. Radiother Oncol 2009, 93(3):503-509.
13. Silander E., Nyman J., Bove M., et al. Impact of prophylactic percutaneous endoscopic gastrostomy on malnutrition and quality of life in patients with head and neck cancer: a randomized study. Head Neck 2012, 34(1):1-9.
14. Grant D.G., Bradley P.T., Pothier D.D., et al. Complications following gastrostomy tube insertion in patients with head and neck cancer: a prospective multi-institution study, systematic review and meta-analysis. Clin Otolaryngol 2009, 34(2):103-112.
15. Mekhail T.M., Adelstein D.J., Rybicki L.A., et al. Enteral nutrition during the treatment of head and neck carcinoma: is a percutaneous endoscopic gastrostomy tube preferable to a nasogastric tube?. Cancer 2001, 91(9):1785-1790.
16. Machtay M., Moughan J., Trotti A., et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. JClin Oncol 2008, 26(21):3582-3589.
17. Lee W.T., Akst L.M., Adelstein D.J., et al. Risk factors for hypopharyngeal/upper esophageal stricture formation after concurrent chemoradiation. Head Neck 2006, 28(9):808-812.
18. Chen A.M., Li B.Q., Lau D.H., et al. Evaluating the role of prophylactic gastrostomy tube placement prior to definitive chemoradiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2010, 78(4):1026-1032.
19. Corry J. Feeding tubes and dysphagia: cause or effect in head and neck cancer patients. JMed Imaging Radiat Oncol 2009, 53(5):431-432.
20. Chen A.Y., Frankowski R., Bishop-Leone J., et al. The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M. D. Anderson dysphagia inventory. Arch Otolaryngol Head Neck Surg 2001, 127(7):870-876.
21. Prestwich R.J., Oksuz D.C., Dyker K., Coyle C., Sen M. Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with cisplatin concurrent chemoradiotherapy for nonmetastatic stage IV head-and-neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 2011, 81(4):e237-e243.
22. Prestwich R.J., Kancherla K., Oksuz D.C., et al. Asingle centre experience with sequential and concomitant chemoradiotherapy in locally advanced stage IV tonsillar cancer. Radiat Oncol 2010, 5:121.
23. Kanatas A.N., Rogers S.N. Aguide of the questionnaires used in the measurement of health-related quality of life in head and neck oncology. Tumori 2008, 94(5):724-731.
24. Oozeer N.B., Corsar K., Glore R.J., et al. The impact of enteral feeding route on patient-reported long term swallowing outcome after chemoradiation for head and neck cancer. Oral Oncol 2011, 47(10):980-983.
25. Bhayani M.K., Hutcheson K.A., Barringer D.A., et al. Gastrostomy tube placement in patients with oropharyngeal carcinoma treated with radiotherapy or chemoradiotherapy: factors affecting placement and dependence. Head Neck 2013, 35(11):1634-1640.